Holland & Barrett has been transformed to take advantage of a ‘structural shift’ towards wellness, now group CEO Anthony Houghton has his sights on its next chapter.
Four years ago, Holland & Barrett was in poor health. Mired in £700m of debt, losses grew to £31.5m as it endured a bitter dispute with suppliers over late payments.
Today, it’s a business transformed. Latest results to September 2025 showed revenue growth hit double figures for the third consecutive year, growing 11% to £981m. Gross profits surged to £579.9m following its “strongest ever” year of trade. Reports also suggest its tetchy relationship with suppliers is a thing of the past.
On paper, it could be one of the sector’s most impressive turnarounds of recent years, which is why group CEO Anthony Houghton’s diagnosis of what’s driven the success is surprising. “We’re in the right sector,” he tells The Grocer. But that’s only part of the story.
True, as the UK’s largest health and wellness retailer, H&B was well placed to take advantage of what Houghton calls a “structural shift” in consumers’ attitudes towards health and wellness since Covid. Nonetheless, it’s long been understood that the business desperately needed investment to make its offer more relevant.
“Luckily, we’ve been supported to literally rebuild the foundations from bottom up,” says Houghton.
Since buying back £700m of H&B’s debt, leaving it debt-free, owner LetterOne has ploughed over £350m into reviving its stores and supply chain, investing £124m in 2025 alone. This is most visible in H&B’s expanded and completely modernised store estate. “We had stores in the wrong location, wrong size or not to the right standard. We’ve relocated or consolidated, so we’re in the right places and offer the right service.”
Forty-seven stores were opened last year, and a further nine already in 2026 have taken its UK store estate to 809. These have been bolstered with concessions in Tesco, Morrisons, Co-op, WH Smith and Next, as well as digital marketplaces with Ocado. It’s also expanded internationally across Benelux, the Middle East, China and more, with stores in 21 countries globally.
Name: Anthony Houghton
Lives: Manchester
Family: Three sons aged 22, 17 and 14
Potted CV: Operations roles (Currys, Phones 4u, Woolworths), stores director (Home Retail Group), retail director (Wilko), group retail & property director, chief operating officer, UK MD, and group CEO (H&B).
Best business advice I’ve ever been given: Surround yourself with people better than you and help them to be the best of themselves.
Career highlight: Joining Holland & Barrett – a business that sells products and services that make a positive difference to people’s lives.
Favourite Holland & Barrett product: H&B Expert Triple Action Biotic to support my gut health.
Its 4,500 store staff also play a vital role. Over the past three years, H&B has invested more into training and people than ever. Store staff are now trained as “wellness advisers”, so they can confidently discuss products to help with customers’ basic health concerns. It’s also established an in-house science team that plays a key role in NPD from its development centre in London, and recently opened a contact centre that shoppers can call for virtual 15-minute health consultations.
“Training is one of our biggest investments. It’s one of the easiest things to scale back when faced with increasing costs, but it’s definitely paid off,” Houghton says, citing “record” customer and staff satisfaction scores.
Meanwhile, about 2,700 of H&B’s 4,500 SKUs have been replaced over the past three years, including a reset of its food category in 2023 to better reflect shopper visits and social media health trends. More than 1,000 of its SKUs are now own label, accounting for half of total sales.
Aisles, both physical and online, are now categorised for specific ‘health missions’ – such as Skin, Gut Health or Joints, Bones and Muscles – and packed with products like premium collagen, magnesium butter and mushroom coffee. Growing concession partnerships with the likes of Randox Health Clinics are also key.
“We want to give customers the opportunity to understand what’s going on in the body. More often than not, that leads to sales of supplements,” Houghton says.

That change is not confined to customers either. A £43.5m investment into tech in 2025 birthed new checkouts, stock systems, an e-commerce platform, app and more. However, the completion of a three-year project to automate its Burton distribution centre earlier this year is set to have the biggest impact.
“We’ve gone from pen and paper to everything being automated and digitised,” Houghton says. “It allows us to improve how we manage stock end to end.”
Major restructure
In September, Holland & Barrett entered the “next chapter” of its growth strategy with a major restructure of its senior team. Three business units were consolidated into one team under Houghton, who was promoted from UK CEO to group CEO. Guy Farmer was promoted to chief commercial officer, Ian Clark was promoted to chief strategy officer and Jacopo Mor became chief digital officer. The team will be boosted further when former Vision Express MD Steve Worboys joins as chief operating officer this month.
“There’s no negative here,” Houghton says. “We needed to improve accountability. We needed faster decision making. We wanted end-to-end ownership and stronger integration across the group.”
Houghton believes that ultimately the huge investments and boardroom restructure will help H&B take advantage of the plentiful room for growth the business has in a booming UK health and wellness market.

That does mean “more stores”, but it also means ramping up the capabilities of its newly relaunched loyalty programme, H&BandMe, by adding new personalisation and rolling out dedicated membership prices.
He also senses an opportunity to own the growing space triggered by GLP-1 weight-loss drugs. “We see it as a catalyst for change, not a threat,” he says. He believes H&B’s offering means it can provide a “wraparound service” for those on the drugs, and reveals the brand is developing a range to support it.
Just like GLP-1s, which remain in their infancy, Houghton believes H&B is only just beginning to unlock the benefits of its own wellness journey. And he’s focused on making sure it remains at peak fitness.
“We’ve been fixing the foundations. We’re through the pain. Now, it’s about how we start to get some return on these investments.”







No comments yet